InterSystems Wins Frost & Sullivan 2012 European Company of the Year Award in Integrated Connected Health Technologies

InterSystemsInterSystems Corporation, a global leader in software for connected care, has been awarded the Frost & Sullivan 2012 European Company of the Year Award in Integrated Connected Health Technologies. Frost & Sullivan cited InterSystems for both its product innovation and its ability to deliver excellent customer value. In particular Frost & Sullivan’s analysts praised the InterSystems HealthShare® strategic informatics platform, which it described as "a one-stop solution that enables users to capture, share and understand and act on all their data, both structured and unstructured".

InterSystems was benchmarked against its competitors in five key areas:

  • Degree of innovation with products and technologies
  • Leadership in customer value
  • Growth strategy excellence
  • Growth implementation excellence
  • Leadership in market penetration

"The importance of integrated, connected care cannot be overstated as a key requirement for the next generation of healthcare informatics. With the ability to continuously derive value from their information and make it actionable at the point of care, health organisations can achieve the breakthrough transformation they need to address the challenges of managing costs while improving the quality of care," said Dominick Bizzarro, Global Business Manager, InterSystems HealthShare.

InterSystems HealthShare is a strategic healthcare informatics platform for hospitals, integrated delivery networks, and regional and national health information exchanges.

It is built on the InterSystems Caché® database and InterSystems Ensemble® integration platform. InterSystems DeepSee provides embedded real-time business intelligence capabilities, and InterSystems iKnow provides the ability to discover concepts and relationships within unstructured data.

The judges highlighted InterSystems' successful nationwide projects in countries including Sweden, Denmark, the Netherlands, and Scotland. They also cited InterSystems' growing reputation as a creative technology partner focused on advancing its implementation technology and post-implementation support to ensure customers achieve and exceed the expected value.

"Frost & Sullivan believes that InterSystems’ business strategy is customer-focused, and this has helped it to provide technologies that are widely used in the healthcare space. Its applications embed interoperability, analytics and other key components, which help its customers gain a competitive edge. All of these factors help InterSystems emerge as the worthy recipient of the 2012 Frost & Sullivan Company of the Year Award in the European Integrated Connected Health Technologies Market," said Divyaa Ravishankar, Senior Research Analyst, Healthcare and Lifescience IT, Frost & Sullivan.

"This award is excellent recognition for the work we are doing in Europe," said Jonathan Selby, UK & Ireland Country Manager at InterSystems. "We are continuing to grow our footprint in the European market by delivering outstanding technical innovation, real value for our partners and customers, and a connected care strategy that is ultimately focused on improving patient outcomes."

Related news articles:

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

About InterSystems
InterSystems Corporation is a global leader in software for connected care, with headquarters in Cambridge, Massachusetts, and offices in 25 countries. InterSystems CACHÉ® is the world's most widely used database system in clinical applications. InterSystems Ensemble® is a platform for rapid integration and the development of connectable applications. InterSystems HealthShare™ is a strategic healthcare informatics platform for information exchange and analytics within a hospital network, and across a community, region or nation. InterSystems' products are used by thousands of hospitals and laboratories worldwide, including all of the top ten hospitals on the Honor Roll of America's Best Hospitals as rated by U.S. News and World Report.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...